| Current Price | $10.63 | Mkt Cap | $144.80M |
|---|---|---|---|
| Open | $10.75 | P/E Ratio | 15.90 |
| Prev. Close | $10.75 | Div. (Yield) | N/A (N/A) |
| Daily Range | $10.56 - $10.86 | Volume | 47,617 |
| 52-Wk Range | $5.24 - $11.67 | Avg. Daily Vol. | 0 |
News & Discussion Boards
- Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference on February 7 2/2/2012 1:00:00 PM -
- Biotechnology FDA Approval Catalyst Strategy 1/13/2012 5:24:38 AM -
- Anika Therapeutics to Present at the Eighth Annual Noble Financial Equity Conference on January 17 1/10/2012 10:48:00 AM -
- Anika Therapeutics Announces U.S. MONOVISC® License and Supply Agreement with DePuy Mitek, Inc. 12/21/2011 3:34:00 PM -
- Anika Therapeutics CEO Discusses Q2 2011 Results - Earnings Call Transcript 8/5/2011 2:50:25 PM
- Anika Therapeutics Shares May Rebound 5/5/2011 6:50:24 PM
- Anika Therapeutics' CEO Discusses Q1 2011 Results - Earnings Call Transcript 5/5/2011 2:19:02 PM
- Anika Therapeutics' CEO Discusses Q1 2011 Results - Earnings Call Transcript 5/5/2011 2:19:02 PM
| Subject | Recs | Author | Date |
|---|


